论文部分内容阅读
我院自1990.2～1991.9对10例AMI患者进行了经静脉大剂量尿激酶冲击疗法,并与同时期12例常规疗法的患者进行对照。溶栓组10例,均为男性。平均52.1岁。冠心病9例,风心病1例。前壁4例。下壁3例,下壁+右室梗塞2例,下壁+正后壁1例。并发心律失常4例,心衰7例,心源性休克3例。对照组12例,男11例,女1例,平均59.2岁。前壁6例,下壁5例,下壁+高侧壁1例。并发心律失常8例,心衰5例,死亡1例。入院后诊断一经明确,即给尿激酶120～190u～在15～30分内静脉滴入。AMI发病至用药时间平均2.3小时。用时给吸氧镇痛,丹参、低分子右旋醣酐、极化液静滴。阿斯匹林,潘生丁口服。用药过程中连续心电监护。用药前后检测血小板。出凝血时间,凝血酶原时间,纤维蛋
Our hospital from 1990.2 ~ 1991.9 on 10 patients with AMI by intravenous high-dose urokinase impact therapy, and with the same period in 12 cases of conventional therapy in patients with control. Thrombolytic group of 10 patients, all men. Average 52.1 years old. Coronary heart disease in 9 cases, rheumatic heart disease in 1 case. Anterior wall in 4 cases. 3 cases of inferior wall, 2 cases of inferior wall + right ventricular infarction, 1 case of inferior wall + posterior wall. 4 cases of arrhythmia, heart failure in 7 cases, cardiogenic shock in 3 cases. Control group of 12 patients, 11 males and 1 female, with an average of 59.2 years old. 6 cases of anterior wall, inferior wall in 5 cases, inferior wall + high side wall in 1 case. 8 cases of arrhythmia, heart failure in 5 cases, 1 case of death. Once the diagnosis of admission is clear, give urokinase 120 ~ 190u ~ in 15 to 30 minutes intravenously. AMI onset to medication average 2.3 hours. When used to oxygen and analgesic, Salvia, low molecular weight dextran, intravenous infusion. Aspirin, dipyridamole oral. Continuous ECG monitoring during medication. Test platelets before and after treatment. Clotting time, prothrombin time, fibrin